- Home
- EBMT vs ELTX Comparison
EBMT vs ELTX Comparison
Compare EBMT & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- ELTX
- Stock Information
- Founded
- EBMT 1922
- ELTX 2011
- Country
- EBMT United States
- ELTX United States
- Employees
- EBMT N/A
- ELTX N/A
- Industry
- EBMT Major Banks
- ELTX Biotechnology: Pharmaceutical Preparations
- Sector
- EBMT Finance
- ELTX Health Care
- Exchange
- EBMT Nasdaq
- ELTX Nasdaq
- Market Cap
- EBMT 134.3M
- ELTX 158.5M
- IPO Year
- EBMT N/A
- ELTX N/A
- Fundamental
- Price
- EBMT $16.63
- ELTX $9.15
- Analyst Decision
- EBMT
- ELTX Strong Buy
- Analyst Count
- EBMT 0
- ELTX 1
- Target Price
- EBMT N/A
- ELTX $13.00
- AVG Volume (30 Days)
- EBMT 20.7K
- ELTX 110.4K
- Earning Date
- EBMT 10-28-2025
- ELTX 11-13-2025
- Dividend Yield
- EBMT 3.49%
- ELTX N/A
- EPS Growth
- EBMT 58.15
- ELTX N/A
- EPS
- EBMT 1.72
- ELTX N/A
- Revenue
- EBMT $87,531,000.00
- ELTX N/A
- Revenue This Year
- EBMT N/A
- ELTX N/A
- Revenue Next Year
- EBMT $6.26
- ELTX N/A
- P/E Ratio
- EBMT $9.66
- ELTX N/A
- Revenue Growth
- EBMT 9.36
- ELTX N/A
- 52 Week Low
- EBMT $14.35
- ELTX $4.60
- 52 Week High
- EBMT $18.49
- ELTX $12.62
- Technical
- Relative Strength Index (RSI)
- EBMT 51.92
- ELTX 51.67
- Support Level
- EBMT $16.05
- ELTX $7.87
- Resistance Level
- EBMT $16.50
- ELTX $8.99
- Average True Range (ATR)
- EBMT 0.33
- ELTX 0.53
- MACD
- EBMT 0.05
- ELTX 0.08
- Stochastic Oscillator
- EBMT 81.82
- ELTX 82.72
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.